Landauer Inc

Landauer — Investor Presentation (December 2011)

33 slides from Landauer's investor presentation, Dec 7, 2011

  1. Slide 1: Landauer, Inc. Investor Presentation December 2011

    LANDAUER, INC. Investor Presentation December 2011 Until superseded, this presentation will available at the Company website –www.landauer.com -in the Investors section.

  2. Slide 2: Safe Harbor Statement

    This presentation may contain forward-looking statements, including statements about the outlook and prospects for Company and industry growth, as well as statements about the Company’s future financial and operating performance. Some of the information shared here constitutes forward-looking statem

  3. Slide 3: Landauer at a Glance

    Landauer at a Glance  1954 Founded  Glenwood, IL Headquarters  550 Employees  78,000+ Annual Customers Served  1.7 million Annual Individuals Served  94%+ Customer Retention Rates  $120.5M FY2011 Revenue  ~90% Recurring Revenue  20+ Consecutive Years of Revenue Growth  $44.4M FY2011 EBITDA

  4. Slide 4: Investment Highlights

    Investment Highlights x Comprehensive Portfolio of Best-in-Class Service Offerings and Technology x Market Leading Positions in Attractive Segments x Global, Integrated Platform and Infrastructure x Large, Diverse Client Base Generating Recurring Revenue x Deep and Experienced Management Team x Comp

  5. Slide 5: Landauer Strategy Overview

    Value Creation Deliver Upside Growth 1.Optimize Core 2.Competitive Growth 3. Strategic Expansion Strategic Priorities Landauer Strategy Overview Strategic ExpansionOptimize the Core Competitive Growth  New Management in 2006  Restructure: Cost  IT/ERP system upgrades  OSL / InLight –new internat

  6. Slide 6: Radiation Safety Continuum

    Radiation Safety Continuum Existing Services with Penetration Opportunities* Complementary Adjacent Products / Services _____________________ (1) Average Revenue per Facility greater than $400K. Along the Radiation Safety Continuum 6 IZI Medical Physics Core Business Greater than $1.1 Billion U.S. M

  7. Slide 7: Transition of Landauer Financial Metrics

    7 Transition of Landauer Financial Metrics FY 20125 Year Guidance Sales Mix: 2006 2007 2008 2009 2010 2011 CAGR Midpoint Radiation Monitoring 79.0$ 83.7$ 90.0$ 93.8$ 100.3$ 99.9$ 4.8% Medical Physics 14.0$ 20.6$ N/A Consumable Medical Accessories N/A Consolidated Revenue 79.0$ 83.7$ 90.0$ 93.8$ 114.

  8. Slide 8: Long Track Record of Growth and Innovation

    Long Track Record of Growth and Innovation 1954 1968 1991 1995 2003 2006 2008 2010 2009 Landauer is founded Tech/Ops Landauer changes name to Landauer, Inc. 2011 Introduces InLight® dosimetry system Signs first long- term military contract ($12M) ($ in millions) 20+ Years of Consistent Revenue Growt

  9. Slide 9: Deep and Experienced Management Team

    Deep and Experienced Management Team Name Title Prior Experience Bill Saxelby President & CEO Medical Research Laboratories Baxter International Craig Yoder, PhD SVP, Marketing & Technology Pennsylvania Power and Light Battelle, Pacific Northwest Laboratory Michael Leatherman Interim CFO Wallace Com

  10. Slide 10: Global, Integrated Platform and Infrastructure

    Global, Integrated Platform and Infrastructure 10 National Offices Subsidiaries Affiliates InLight Installations 8% 17% 75% Geographic Revenue Mix Fairborn, OH Flint, TX São Carlos, Brazil Ibaraki-ken, Japan Oxford, U.K. Beijing, China Drummoyne, Australia Fontenay-Aux-Roses Cedex, France Mexico Cit

  11. Slide 11: Landauer Business Overview

    Landauer Business Overview Investor Presentation December 2011 11

  12. Slide 12: Radiation Safety Continuum

    Radiation Safety Continuum Occupational Radiation Monitoring “Radiation Dose to Workers” x Market leader in radiation dosimetry services and equipment x Full range of products and services utilizing proprietary technology continually evolving over 50 years x Utilize proprietary OSL dosimetry technol

  13. Slide 13: Occupational Radiation Monitoring Segment Overview

    Occupational Radiation Monitoring Segment Overview Service & Product Offering Overview  84% contracted services / 16% equipment  Occupational Radiation Monitoring ― Radiation exposure measurement and monitoring ― Full-service technical, analytical and client support ― Servicing healthcare, energy,

  14. Slide 14: Occupational Radiation Monitoring: Competitive Differentiators

    Occupational Radiation Monitoring Segment Overview Competitive Differentiators x Proprietary OSL (Optically Stimulated Luminescence) and InLight®technology x Immediate notification of radiation overexposure x Complete historical records for individuals monitored x Online data and account management

  15. Slide 15: Military and Emergency Response Market Opportunity

    Military and Emergency Response Market Opportunity  Expanding application of next generation technology to pursue global military and first responder radiation monitoring markets  The U.S. military issued orders totaling $12.5 million to upgrade the Army’s tactical dosimetry capabilities, which wi

  16. Slide 16: Emergency Response Mutual Aid / Synchronization

    Emergency Response Mutual Aid / Synchronization 16

  17. Slide 17: Occupational Radiation Monitoring Market

    $235 $365 Occupational Radiation Monitoring Market Market Dynamics / Opportunity Size / Mix x Annual growth rates of 3% to 5% (international growing faster) x Heightened awareness and concern for worker safety and more workers in contact with radiation driving increased demand x Further expansion of

  18. Slide 18: Medical Physics Segment Overview

    Medical Physics Segment Overview Service Offering Overview  Full-service, national medical physics practice group ― Therapy physics ― Diagnostic physics ― Equipment commissioning services ― Accreditation support  ~ 90% of revenue is recurring  Provides full scope medical physics services to: ― Ho

  19. Slide 19: Medical Physics Demand and Supply Trends

    •New accreditation requirements for imaging reimbursement oMedicare and private payers oAnnual calibration and testing •Growth in equipment placement oDiagnostic imaging oLinear accelerators •Increasing physicist oversight of radiation departments •Technological improvements and complexities in imag

  20. Slide 20: Medical Physics: Competitive Differentiators

    Medical Physics Segment Overview Competitive Differentiators x Largest company in the sector with broadest reach and widest array of service capabilities — National infrastructure nearly complete x Unmatched network of board-certified and board-eligible medical physicists x Blue chip client base x 1

  21. Slide 21: Medical Physics Areas of Expertise and Services

    Therapeutic Diagnostic Nuclear Medical Area of Expertise • Radiation Treatment • Radiology/Imaging • Nuclear Medicine Overview of Responsibilities & Services Offered • Selection, acceptance testing commissioning, calibration, and annual surveys of linear accelerators (linacs), simulators, and treatm

  22. Slide 22: Medical Physics Market

    Medical Physics Market Market Dynamics / OpportunitySize / Mix x $1.0 billion domestic market (largest player in market –by 3x) x Approximately 6,000 hospitals perform 37 million nuclear medicine procedures per year (10 million in U.S.) x Radiopharmaceutical utilization growing at over 10% per year

  23. Slide 23: IZI Medical Products

    IZI Medical Products  1991 Founded  Baltimore, MD Headquarters  30 Employees  $14M Revenue YTD (nine months ended 9/30)  100% Recurring Revenue  1,000+ Annual Customers Served ($ in millions) History of Strong Revenue Growth Company Overview  Provides high quality medical accessories used in

  24. Slide 24: IZI Acquisition Overview

    IZI Acquisition Overview  In November 2011, acquired 100% of the outstanding equity of IZIMedical Products for approximately $93 million cash, subject to certain customary purchase price adjustments  The acquisition is expected to be $0.12 to $0.16 accretive to EPS (earnings per share) in fiscal 2

  25. Slide 25: IZI Medical Products Overview

    IZI Medical Products Overview  Spherz® ― Sterile, disposable passive reflective markers aid registration and instrument tracking during image guided surgery procedures  Multi-Modality Markers ― Artificial reference points used on radiology image to provide clear and accurate reference point on sca

  26. Slide 26: IZI Broad and Diverse Customer Base

    IZI –Broad and Diverse Customer Base  IZI’s customer base includes buyers at several stages along the supply chain including distributors, manufacturers of image guided navigation equipment, and product end users ― Medtronic ― Stryker ― Integra Radionics  Targets community hospitals, radiation onc

  27. Slide 27: Financial Overview

    Financial Overview 27 Investor Presentation December 2011

  28. Slide 28: Landauer Financial Overview

    Landauer Financial Overview ($ in millions, FYE 9/30) Revenue ($ in millions, FYE 9/30) EBITDA  Approximately 90% of revenue derived from subscription and is recurring in nature  Core business growing organically in the 3% to 5% range going forward  Contract with U.S. military to replace its anti

  29. Slide 29: Recent Financial Performance

    Recent Financial Performance 29 Fiscal 2011 Highlights  Revenue grew 5.3 percent to $120.5 million.  Gross profit grew 4.4 percent to $72.9 million on increased revenue and mix.  Operating income increased $0.3 million, to $34.9 million.  Net income rose 3.6 percent to $24.5 million, or $2.58 pe

  30. Slide 30: Landauer's Strong and Stable Balance Sheet

    Landauer’s Strong and Stable Balance Sheet 30 Summary Consolidated Balance Sheet (September 30, 2011) ($ in millions) Current Assets Liabilities Cash $ 7.9 Accounts Payable $ 5.4 Accounts Receivable 25.5 Dividends Payable 5.3 Other Current Assets 17.2 Deferred Income 14.7 Total Current Assets $ 50.6

  31. Slide 31: Historical Financial Performance

    *Note: Fiscal 2009 Net Income excludes $1.8M after-tax impact of charges *Note: Fiscal 2009 Net Income excludes $1.8M after-tax impact of charges Historical Financial Performance 31 Revenue, Net Income & Cash Flow from Operations ($ in Millions)

  32. Slide 32: Competitive Dividend Policy

    32 Competitive Dividend Policy Increasing Dividends per Share

  33. Slide 33: Guidance Fiscal 2012 Outlook

    Guidance 33 Fiscal 2012 Outlook  Expected Revenue $150 to $157 million, which includes 10 months of contribution from the November 2011 IZI Medical Products acquisition – $4.4 million ($2.9 million net of tax) of non-recurring expense spending to support the successful completion of the Company’s s

Landauer — Investor Presentation (December 2011) on 6ix